Google Finance: notícies i preu de les accions del tíquer BB Biotech 2nd Line Ord Shs (BBZA)

Pàgina d'iniciBBZA • ETR

BB Biotech 2nd Line Ord Shs

28,40 €

7 d’abr., 18:30:22 GMT+2 · EUR · ETR · Exempció de responsabilitat

AccióValor cotitzat de: DEAmb seu a: CH

Tancament anterior

29,20 €

Interval de preus d'avui

25,65 € - 29,60 €

Interval anual

25,65 € - 45,95 €

Capitalit. borsària

1457,02 M CHF

Volum mitjà

34,09 k

Ràtio PER

Rendibilitat per dividend

Borsa principal

SWX

Notícies dels mercats

The New York Times

fa 1 hora

What Is a Bear Market? Are We in One?

CBS News

fa 3 hores

Stock market whipsaws as economists cite recession risks

Yahoo Finance

fa 3 hores

Stocks could do something today that hasn't happened since the Great Depression

AP News

fa 9 minuts

Trump threatens more tariffs on China as global markets plunge

Fox Business

fa 1 hora

Stocks sink for third session in tariff pushback: Live Updates

Why Cava Stock Was Down 23% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022

.INX

0,54 %

Informació

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Data de fundació

9 de nov. 1993

Seu principal

Küsnacht, Zuric
Suïssa

Lloc web

bbbiotech.ch

Empleats